CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −7,157 | $32.13 | $230K | 86,590 |
| 2024-04-01 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −3,401 | $32.12 | $109K | 104,594 |
| 2024-04-01 | Burrell Terry-Ann Chief Financial Officer | Sale 10b5-1 | −5,446 | $32.12 | $175K | 70,137 |
| 2024-04-01 | Evans John M. CEO | Sale 10b5-1 | −18,102 | $32.13 | $582K | 1,058,343 |
| 2024-04-01 | Ciaramella Giuseppe President | Sale 10b5-1 | −4,534 | $32.12 | $146K | 169,616 |
| 2024-03-31 | Burrell Terry-Ann Chief Financial Officer | Grant or award | +27,500 | 75,583 | ||
| 2024-03-31 | Simon Amy Chief Medical Officer | Grant or award | +27,500 | 93,747 | ||
| 2024-03-31 | Ciaramella Giuseppe President | Grant or award | +35,000 | 174,150 | ||
| 2024-03-31 | Bellon Christine Chief Legal Officer | Grant or award | +27,500 | 107,995 | ||
| 2024-03-31 | Evans John M. CEO | Grant or award 10b5-1 | +77,500 | 1,076,445 | ||
| 2024-03-28 | Evans John M. CEO | Sale 10b5-1 | −60,000 | $33.86 | $2.0M | 998,262 |
| 2024-02-14 | FMR LLC See Remark 1 | Sale | −854,323 | $30.51 | $26.1M | 1,281,188 |
| 2024-02-14 | FMR LLC See Remark 1 | Sale | −45,677 | $31.34 | $1.4M | 1,235,511 |
| 2024-02-13 | FMR LLC See Remark 1 | Sale | −410 | $30.28 | $12K | 2,773,068 |
| 2024-02-13 | FMR LLC See Remark 1 | Sale | −1,155 | $30.93 | $36K | 2,771,913 |
| 2024-01-31 | Burrell Terry-Ann Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | $24.40 | $1.3M | 55,000 |
| 2024-01-31 | Bellon Christine Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | $24.40 | $1.3M | 55,000 |
| 2024-01-31 | Simon Amy Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | $24.40 | $1.3M | 55,000 |
| 2024-01-31 | Evans John M. CEO | Sale 10b5-1 | −60,000 | $25.33 | $1.5M | 1,058,262 |
| 2024-01-31 | Evans John M. CEO | Grant or award · Stock Option (Right to Buy) 10b5-1 | +155,000 | $24.40 | $3.8M | 155,000 |
Page 9 of 32 · 630 trades